Emerging And Re Emerging Infectious Disease Vaccines 09 Dec08 Final
20 likes3,725 views
The document discusses emerging and re-emerging infectious diseases, the pathogens involved, their geographical prevalence, and the socio-economic and environmental factors contributing to their resurgence. It identifies market opportunities for new vaccines, funding sources, and addresses challenges in development, clinical trials, and regulatory processes. Key pathogens mentioned include Burkholderia pseudomallei and Norovirus, both of which are associated with significant health impacts and overlooked vaccine opportunities.
1 of 24
Ad
Recommended
Emerging and re emerging infections
Emerging and re emerging infectionsAnand Prakash
油
This document provides an overview of emerging and re-emerging infectious diseases. It defines emerging diseases as those whose incidence in humans has increased in recent decades and re-emerging diseases as those that were previously controlled but are increasing again. Factors contributing to disease emergence include evolution of pathogens, changes in human susceptibility and behavior, and environmental changes. The epidemiological triad of host-agent-environment interactions that drive disease transmission is discussed. Several major emerging diseases are outlined such as SARS, Ebola, Nipah virus, and drug-resistant bacteria and their characteristics and origins. Prevention relies on surveillance, research, infrastructure, and public health responses.Emerging and re emerging diseases (part 1 of 2)
Emerging and re emerging diseases (part 1 of 2)Dr. Mamta Gehlawat
油
This document discusses several emerging and re-emerging infectious diseases including SARS, MERS, Nipah virus, Chikungunya, West Nile virus, Lyme disease, Kyasanur forest disease. It provides details on the causative agents, modes of transmission, symptoms, treatment and prevention measures for each disease. It also discusses definitions of emerging and re-emerging diseases and factors responsible for their emergence or re-emergence such as rapid population growth, international travel, antibiotic resistance.Role of climate change in epidemiology of infectious diseases
Role of climate change in epidemiology of infectious diseasesILRI
油
The document discusses the role of climate change in the epidemiology of infectious diseases, highlighting the collaboration of the Field Epidemiology and Laboratory Training Programme in Kenya with various health organizations to address public health threats. It emphasizes the impact of climate change on infectious diseases, including vector-borne, flood-associated, and food-borne diseases, and the necessity for adaptation and intervention strategies for public health professionals. Key concepts include the 'One Health' approach that integrates human, animal, and environmental health and the potential implications of climate variability on disease dynamics.Emerging infections
Emerging infectionsmohammed Abo Elmagd
油
This document discusses emerging and re-emerging infectious diseases. It begins by quoting Girolamo Frascatoro who spoke about syphilis in the 15th century, noting diseases will reoccur. Microbes evolve faster than humans. Infectious diseases have significantly impacted history, like the Black Plague. Emerging diseases are new, while re-emerging were previously controlled but increasing. Factors contributing to emergence include microbial adaptation, human behavior, and environmental changes. Examples discussed are MERS, Ebola, SARS, avian influenza, Zika virus, and potential bioterrorism agents. Preventing emergence requires surveillance, research, infrastructure, training, and prevention/control strategies.Influenza
Influenzathegowda
油
Infectious disease epidemiology describes influenza as an acute viral infection typically causing abrupt onset of fever and respiratory symptoms like cough and sore throat. Complications can include primary viral or secondary bacterial pneumonia. Influenza viruses are transmitted through respiratory secretions when people cough, sneeze or talk. There are annual epidemics in winter months in temperate regions that vary in severity each year. Pandemics occur less frequently and represent major antigenic shifts in influenza virus subtypes. Surveillance, vaccines, antiviral drugs, rest, and handwashing help prevent and treat influenza.Arboviruses
ArbovirusesJasmine John
油
The document discusses several arthropod-borne diseases transmitted by mosquitoes, ticks, and fleas including malaria, yellow fever, dengue fever, encephalitis, epidemic typhus, and bubonic plague. It then focuses on arboviruses, which are viruses transmitted between animals and humans by arthropod vectors like mosquitoes and ticks. Major arboviruses include those in the Togavirus, Bunyavirus, and Flavivirus families that cause diseases such as dengue, yellow fever, Japanese encephalitis, and eastern and western equine encephalitis.Zoonosis
ZoonosisJasmine John
油
Zoonoses, or diseases that can be transmitted between animals and humans, were discussed. Key points included:
- Over 250 known zoonotic diseases ranging from mild to fatal illnesses. Common zoonoses include salmonellosis, Lyme disease, and West Nile virus.
- Diseases are transmitted through various routes such as direct contact, bites, food/water, fomites, and vectors like fleas and ticks.
- At risk groups include those working with animals, in agriculture, recreationally exposed to wildlife, and travelers. Animal reservoirs include dogs, cats, food animals, birds, and wild rodents.Emerging & re emerging infections
Emerging & re emerging infectionsswati shikha
油
This document discusses emerging and re-emerging infectious diseases. It defines emerging diseases as those caused by new pathogens or new variants of old pathogens. Re-emerging diseases are those that were previously controlled but have returned. Factors responsible include population growth, travel, antibiotic overuse, and environmental changes. Examples of emerging diseases discussed are Ebola virus, Zika virus, Nipah virus, and Lassa fever. Malaria and dengue are provided as examples of re-emerging diseases. Public health actions to address these diseases include surveillance, research, information sharing, and strengthening public health systems.Influenza(Virology)
Influenza(Virology)Md.Riaz Sarker
油
The document summarizes key information about influenza virus. It belongs to the Orthomyxoviridae family and is a segmented, single-stranded RNA virus. It causes the highly contagious disease influenza, or flu. There are three main types - A, B, and C - with Type A being the most virulent and causing pandemics through antigenic drift and shift. Symptoms include fever, cough, and fatigue. Treatment involves antiviral drugs and vaccination, while prevention focuses on hand washing and avoiding contact with infected individuals.Molecular epidemiology an introduction
Molecular epidemiology an introductionBhoj Raj Singh
油
This document provides an overview of molecular epidemiology, including definitions, applications, tools, and attributes. It defines molecular epidemiology as the combination of molecular biology and epidemiology to study disease distribution and determinants at the molecular level. The document outlines several molecular epidemiology techniques like fingerprinting pathogens using pulsed-field gel electrophoresis and multilocus sequence typing. It also discusses how molecular epidemiology can be used descriptively to examine disease distribution and analytically to evaluate associations with risk factors.Covid 19: A Zoonosis
Covid 19: A ZoonosisBhoj Raj Singh
油
COVID-19 is classified as a zoonotic disease, with a significant percentage of infectious diseases originating from animal sources. The document discusses the origins of the SARS-CoV-2 virus, its transmission among humans and animals, and highlights strategies to prevent future zoonotic outbreaks, emphasizing a One Health approach. It underscores the necessity for further research to understand the virus's origins and its hosts to improve control measures for emerging zoonoses.Presentation on Emerging and reEmerging infectious diseases
Presentation on Emerging and reEmerging infectious diseasesBasharat Rashid
油
This document provides an overview of emerging and re-emerging infectious diseases. It discusses trends showing a resurgence of infectious diseases since the late 20th century. Emerging diseases are newly identified agents causing health issues, while re-emerging diseases were previously controlled but are increasing. Factors driving emergence include changes in human, animal and environmental conditions. Examples are given of recent emerging diseases like SARS, avian influenza, and drug-resistant pathogens. National surveillance and global cooperation are needed to monitor, investigate and respond to infectious disease threats.Yersinia pestis presentation
Yersinia pestis presentationSGowthamDhina
油
Yersinia pestis is the bacterium that causes bubonic and pneumonic plague in humans. It is typically transmitted via the bites of infected fleas. There have been three major pandemics of plague throughout history, including the infamous Black Death pandemic of the 14th century that killed approximately 50 million people in Europe. Y. pestis is a gram-negative rod that grows rapidly in blood and tissue fluids. It carries plasmids that are essential for virulence. After being bitten by an infected flea, the bacteria migrate to lymph nodes and multiply, causing swelling, necrosis, and sepsis if untreated. Diagnosis involves identifying the bacteria in smears, cultures, or antibodies. Streptomycin is theOrthomyxovirus
Orthomyxovirus AbilashSundar
油
The document summarizes key information about the Orthomyxoviridae family of viruses, which includes the influenza viruses that cause flu in humans and other animals. It describes the structure and components of influenza virions, how the viruses replicate and spread infection in the host, symptoms and potential complications, methods of diagnosis, host immune response, and approaches for prevention and treatment, including annual flu vaccines tailored to predicted circulating strains and antiviral drugs that can reduce severity of infection.Zoonoses and emerging infectious diseases
Zoonoses and emerging infectious diseasesILRI
油
The document discusses zoonoses and emerging infectious diseases, highlighting their significant impact on human and livestock health and the economic costs associated with pandemics. It outlines the drivers of these diseases, including population growth, land use changes, and environmental degradation, while emphasizing the need for One Health solutions. The document also highlights the burden of zoonoses on poor livestock keepers and suggests that effective surveillance and response strategies can significantly reduce costs related to disease management.Avian influenza
Avian influenzaAshraf ElAdawy
油
Influenza is caused by RNA viruses of the Orthomyxoviridae family that come in three main types: A, B, and C. Influenza A is the most common cause of epidemics and pandemics as it has multiple subtypes that can reassort. Wild aquatic birds are the natural reservoir for all influenza A subtypes. Seasonal epidemics are caused by antigenic drift while pandemics arise due to antigenic shift involving genetic reassortment between human and avian viruses. The prerequisites for an influenza pandemic are a new virus that humans have little immunity to which can spread efficiently between people. Egypt has reported increased human infections of avian influenza A(H5N1) virusE. coli, Klebsiella & proteus
E. coli, Klebsiella & proteusbnsree
油
This document provides information on Escherichia coli, Klebsiella, and Proteus. E. coli is a gram-negative, facultative anaerobe that lives in the intestines and can indicate fecal pollution. Klebsiella is a gram-negative, capsulated bacillus that can cause pneumonia, UTIs, and nosocomial infections. Proteus are gram-negative rods that are opportunistic pathogens responsible for urinary and septic infections, often acquired in hospitals.Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...WHO Regional Office for Europe
油
The document discusses emerging and re-emerging infectious diseases and highlights the need for governance in health, particularly in addressing antimicrobial resistance (AMR) in the WHO European region. It outlines the WHO's action plan to support countries in improving AMR surveillance and healthcare access for migrants, as well as addressing pressing health issues like HIV/AIDS and public health emergencies. The document emphasizes the importance of intersectoral coordination and policy frameworks, like Health 2020, in improving health outcomes across member states.Arboviruses
Arbovirusesraghunathp
油
Arboviruses are viruses that can be transmitted to humans by arthropod vectors such as mosquitoes and ticks. There are approximately 80 known arboviruses that cause human disease. They are classified into families including Togaviridae, Flaviviridae, Bunyaviridae, Reoviridae, and Rhabdoviridae. Some important arboviruses prevalent in India include Chikungunya virus, Dengue virus, Japanese encephalitis virus, Kyasanur forest disease virus, and Sindbis virus. These viruses are transmitted between vertebrate hosts and arthropod vectors in natural cycles and can cause diseases ranging from fever and rash to hemorrhagicArbovirus part 2
Arbovirus part 2Society for Microbiology and Infection care
油
This document provides information on arboviruses and dengue fever. It discusses:
1) Arboviruses belong to three virus families including Togaviruses, Bunyaviruses, and Flaviviruses. Dengue fever is caused by any one of four related flaviviruses.
2) Dengue is the biggest arbovirus problem worldwide, transmitted by Aedes mosquitoes. It causes dengue fever and the potentially lethal dengue hemorrhagic fever/dengue shock syndrome.
3) Diagnosis involves serology to detect IgM and IgG antibodies or isolation of the virus. There is no vaccine or antiviral treatment, so management focuses on supportive care andEmerging and reemerging zoonoses
Emerging and reemerging zoonosesPrajwal nutan
油
This document discusses several emerging and re-emerging zoonoses including bovine spongiform encephalopathy (BSE or mad cow disease), American trypanosomiasis (Chagas disease), cryptosporidiosis, Ebola hemorrhagic fever, cyclosporiasis, hantavirus pulmonary syndrome (HPS), and influenza. It provides definitions, etiologies, epidemiologies, symptoms, diagnoses, and control methods for each disease. The document is presented as part of a class on emerging and re-emerging zoonoses.Arboviral disease and dengue
Arboviral disease and dengueTarek Mahbub Khan
油
The document discusses various aspects of arboviruses, focusing primarily on dengue fever, including its epidemiology, pathogenesis, clinical features, diagnosis, and management strategies. It highlights the dengue virus as a major global health issue, endemic in over 100 countries, and outlines the role of mosquitoes as vectors in transmission. Additionally, the document addresses the challenges in developing dengue vaccines and provides insights into other arboviral diseases like chikungunya and zika.Crimean-Congo Hemorrhagic Fever (CCHF)
Crimean-Congo Hemorrhagic Fever (CCHF)Jibran Mohsin
油
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne viral disease endemic in Pakistan, with outbreaks occurring seasonally. The virus is transmitted by Hyalomma ticks or through contact with infected animal blood or tissues. CCHF has a high mortality rate and presents as a sudden onset fever with hemorrhagic symptoms. Treatment involves supportive care and ribavirin. Prevention focuses on reducing human exposure to ticks through protective clothing, repellents and tick control; as well as safe practices when handling animals or working in healthcare settings.Zoonotic tuberculosis
Zoonotic tuberculosisrajeshneupane00
油
This document provides an overview of zoonotic tuberculosis, which is caused by Mycobacterium bovis and can be transmitted from animals to humans. Key points include:
- M. bovis is one of the main causes of non-pulmonary tuberculosis in humans. It is transmitted through the consumption of unpasteurized dairy or undercooked meat.
- Globally, it is estimated that there are 147,000 new cases of zoonotic tuberculosis annually, with the highest burdens in Africa and Southeast Asia.
- In animals, cattle are the main reservoir and transmission can occur through aerosols or ingestion. Signs include emaciation, fever, and respiratory distress.Introduction mycology
Introduction mycologySk. Mizanur Rahman
油
This document provides an introduction to the topic of mycology. It discusses the key characteristics of fungi, including their eukaryotic nature and cell wall composition of chitin and glucan. Fungi can exist in either yeast or mold forms and many medically important fungi are dimorphic, being able to live in both forms. The document outlines different types of fungal infections and methods for diagnosis, including microscopic examination, serology, culture and nucleic acid probes.Clinical Microbiology in Laboratory
Clinical Microbiology in LaboratoryBhoj Raj Singh
油
The document outlines best practices for sample collection in clinical microbiology, focusing on various specimen types including clinical and non-clinical sources, and emphasizes the importance of proper techniques to avoid contamination and diagnostic errors. It details methods for collecting samples from wounds, abscesses, urine, faeces, and various other tissues, while also discussing the significance of antimicrobial susceptibility testing and the methods employed in this process. Furthermore, it touches on the transportation of samples to ensure viable results and the factors affecting microbial recovery.Malaria ppt
Malaria pptNoe Mendez
油
Malaria is caused by Plasmodium parasites transmitted via mosquito bites. The four species that cause malaria in humans are P. vivax, P. ovale, P. malariae, and P. falciparum, with P. falciparum being the deadliest. Symptoms include fever, chills, and headaches. Treatment involves supportive therapies along with antimalarial drugs like chloroquine, primaquine, mefloquine and combinations of pyrimethamine and sulfadoxin. Prevention focuses on controlling mosquito breeding and protecting against mosquito bites.15. principles of infectious disease 1
15. principles of infectious disease 1Ahmad Hamadi
油
This document discusses infection and infectious diseases. It defines infection as the establishment of foreign organisms in a human host, which can result in colonization or infectious disease. It describes the different types of infectious agents (prions, viruses, bacteria, fungi, protozoa, helminths) and discusses their characteristics. It also covers the normal human flora, factors that influence pathogenesis, and the host immune response to infection.Emerging pathogens
Emerging pathogensdeepak deshkar
油
Emerging pathogens are infectious diseases whose incidence is increasing or threatening to increase. They include diseases that have developed antibiotic resistance or spread to new areas. Major emerging pathogens since the 1970s include HIV, Ebola, SARS, and antibiotic-resistant bacteria like MRSA. Factors driving emergence include increased travel and trade, antibiotic overuse, environmental changes, and evolving pathogens. Controlling emerging diseases requires early detection, diagnosis, treatment, and preventing transmission through vectors and contaminated food/water.Emerging infections dr rosni
Emerging infections dr rosnimayazulkifli
油
This document discusses emerging and re-emerging infectious diseases. It defines emerging infections as diseases that are newly appearing or increasing after past existence. Key factors driving emergence include globalization, antibiotic resistance, and environmental changes. The document lists diseases emerging in Malaysia, including avian influenza, dengue, and drug-resistant pathogens. It emphasizes the importance of accurate laboratory diagnosis and strengthened public health measures and surveillance in addressing emerging threats.More Related Content
What's hot (20)
Influenza(Virology)
Influenza(Virology)Md.Riaz Sarker
油
The document summarizes key information about influenza virus. It belongs to the Orthomyxoviridae family and is a segmented, single-stranded RNA virus. It causes the highly contagious disease influenza, or flu. There are three main types - A, B, and C - with Type A being the most virulent and causing pandemics through antigenic drift and shift. Symptoms include fever, cough, and fatigue. Treatment involves antiviral drugs and vaccination, while prevention focuses on hand washing and avoiding contact with infected individuals.Molecular epidemiology an introduction
Molecular epidemiology an introductionBhoj Raj Singh
油
This document provides an overview of molecular epidemiology, including definitions, applications, tools, and attributes. It defines molecular epidemiology as the combination of molecular biology and epidemiology to study disease distribution and determinants at the molecular level. The document outlines several molecular epidemiology techniques like fingerprinting pathogens using pulsed-field gel electrophoresis and multilocus sequence typing. It also discusses how molecular epidemiology can be used descriptively to examine disease distribution and analytically to evaluate associations with risk factors.Covid 19: A Zoonosis
Covid 19: A ZoonosisBhoj Raj Singh
油
COVID-19 is classified as a zoonotic disease, with a significant percentage of infectious diseases originating from animal sources. The document discusses the origins of the SARS-CoV-2 virus, its transmission among humans and animals, and highlights strategies to prevent future zoonotic outbreaks, emphasizing a One Health approach. It underscores the necessity for further research to understand the virus's origins and its hosts to improve control measures for emerging zoonoses.Presentation on Emerging and reEmerging infectious diseases
Presentation on Emerging and reEmerging infectious diseasesBasharat Rashid
油
This document provides an overview of emerging and re-emerging infectious diseases. It discusses trends showing a resurgence of infectious diseases since the late 20th century. Emerging diseases are newly identified agents causing health issues, while re-emerging diseases were previously controlled but are increasing. Factors driving emergence include changes in human, animal and environmental conditions. Examples are given of recent emerging diseases like SARS, avian influenza, and drug-resistant pathogens. National surveillance and global cooperation are needed to monitor, investigate and respond to infectious disease threats.Yersinia pestis presentation
Yersinia pestis presentationSGowthamDhina
油
Yersinia pestis is the bacterium that causes bubonic and pneumonic plague in humans. It is typically transmitted via the bites of infected fleas. There have been three major pandemics of plague throughout history, including the infamous Black Death pandemic of the 14th century that killed approximately 50 million people in Europe. Y. pestis is a gram-negative rod that grows rapidly in blood and tissue fluids. It carries plasmids that are essential for virulence. After being bitten by an infected flea, the bacteria migrate to lymph nodes and multiply, causing swelling, necrosis, and sepsis if untreated. Diagnosis involves identifying the bacteria in smears, cultures, or antibodies. Streptomycin is theOrthomyxovirus
Orthomyxovirus AbilashSundar
油
The document summarizes key information about the Orthomyxoviridae family of viruses, which includes the influenza viruses that cause flu in humans and other animals. It describes the structure and components of influenza virions, how the viruses replicate and spread infection in the host, symptoms and potential complications, methods of diagnosis, host immune response, and approaches for prevention and treatment, including annual flu vaccines tailored to predicted circulating strains and antiviral drugs that can reduce severity of infection.Zoonoses and emerging infectious diseases
Zoonoses and emerging infectious diseasesILRI
油
The document discusses zoonoses and emerging infectious diseases, highlighting their significant impact on human and livestock health and the economic costs associated with pandemics. It outlines the drivers of these diseases, including population growth, land use changes, and environmental degradation, while emphasizing the need for One Health solutions. The document also highlights the burden of zoonoses on poor livestock keepers and suggests that effective surveillance and response strategies can significantly reduce costs related to disease management.Avian influenza
Avian influenzaAshraf ElAdawy
油
Influenza is caused by RNA viruses of the Orthomyxoviridae family that come in three main types: A, B, and C. Influenza A is the most common cause of epidemics and pandemics as it has multiple subtypes that can reassort. Wild aquatic birds are the natural reservoir for all influenza A subtypes. Seasonal epidemics are caused by antigenic drift while pandemics arise due to antigenic shift involving genetic reassortment between human and avian viruses. The prerequisites for an influenza pandemic are a new virus that humans have little immunity to which can spread efficiently between people. Egypt has reported increased human infections of avian influenza A(H5N1) virusE. coli, Klebsiella & proteus
E. coli, Klebsiella & proteusbnsree
油
This document provides information on Escherichia coli, Klebsiella, and Proteus. E. coli is a gram-negative, facultative anaerobe that lives in the intestines and can indicate fecal pollution. Klebsiella is a gram-negative, capsulated bacillus that can cause pneumonia, UTIs, and nosocomial infections. Proteus are gram-negative rods that are opportunistic pathogens responsible for urinary and septic infections, often acquired in hospitals.Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...WHO Regional Office for Europe
油
The document discusses emerging and re-emerging infectious diseases and highlights the need for governance in health, particularly in addressing antimicrobial resistance (AMR) in the WHO European region. It outlines the WHO's action plan to support countries in improving AMR surveillance and healthcare access for migrants, as well as addressing pressing health issues like HIV/AIDS and public health emergencies. The document emphasizes the importance of intersectoral coordination and policy frameworks, like Health 2020, in improving health outcomes across member states.Arboviruses
Arbovirusesraghunathp
油
Arboviruses are viruses that can be transmitted to humans by arthropod vectors such as mosquitoes and ticks. There are approximately 80 known arboviruses that cause human disease. They are classified into families including Togaviridae, Flaviviridae, Bunyaviridae, Reoviridae, and Rhabdoviridae. Some important arboviruses prevalent in India include Chikungunya virus, Dengue virus, Japanese encephalitis virus, Kyasanur forest disease virus, and Sindbis virus. These viruses are transmitted between vertebrate hosts and arthropod vectors in natural cycles and can cause diseases ranging from fever and rash to hemorrhagicArbovirus part 2
Arbovirus part 2Society for Microbiology and Infection care
油
This document provides information on arboviruses and dengue fever. It discusses:
1) Arboviruses belong to three virus families including Togaviruses, Bunyaviruses, and Flaviviruses. Dengue fever is caused by any one of four related flaviviruses.
2) Dengue is the biggest arbovirus problem worldwide, transmitted by Aedes mosquitoes. It causes dengue fever and the potentially lethal dengue hemorrhagic fever/dengue shock syndrome.
3) Diagnosis involves serology to detect IgM and IgG antibodies or isolation of the virus. There is no vaccine or antiviral treatment, so management focuses on supportive care andEmerging and reemerging zoonoses
Emerging and reemerging zoonosesPrajwal nutan
油
This document discusses several emerging and re-emerging zoonoses including bovine spongiform encephalopathy (BSE or mad cow disease), American trypanosomiasis (Chagas disease), cryptosporidiosis, Ebola hemorrhagic fever, cyclosporiasis, hantavirus pulmonary syndrome (HPS), and influenza. It provides definitions, etiologies, epidemiologies, symptoms, diagnoses, and control methods for each disease. The document is presented as part of a class on emerging and re-emerging zoonoses.Arboviral disease and dengue
Arboviral disease and dengueTarek Mahbub Khan
油
The document discusses various aspects of arboviruses, focusing primarily on dengue fever, including its epidemiology, pathogenesis, clinical features, diagnosis, and management strategies. It highlights the dengue virus as a major global health issue, endemic in over 100 countries, and outlines the role of mosquitoes as vectors in transmission. Additionally, the document addresses the challenges in developing dengue vaccines and provides insights into other arboviral diseases like chikungunya and zika.Crimean-Congo Hemorrhagic Fever (CCHF)
Crimean-Congo Hemorrhagic Fever (CCHF)Jibran Mohsin
油
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne viral disease endemic in Pakistan, with outbreaks occurring seasonally. The virus is transmitted by Hyalomma ticks or through contact with infected animal blood or tissues. CCHF has a high mortality rate and presents as a sudden onset fever with hemorrhagic symptoms. Treatment involves supportive care and ribavirin. Prevention focuses on reducing human exposure to ticks through protective clothing, repellents and tick control; as well as safe practices when handling animals or working in healthcare settings.Zoonotic tuberculosis
Zoonotic tuberculosisrajeshneupane00
油
This document provides an overview of zoonotic tuberculosis, which is caused by Mycobacterium bovis and can be transmitted from animals to humans. Key points include:
- M. bovis is one of the main causes of non-pulmonary tuberculosis in humans. It is transmitted through the consumption of unpasteurized dairy or undercooked meat.
- Globally, it is estimated that there are 147,000 new cases of zoonotic tuberculosis annually, with the highest burdens in Africa and Southeast Asia.
- In animals, cattle are the main reservoir and transmission can occur through aerosols or ingestion. Signs include emaciation, fever, and respiratory distress.Introduction mycology
Introduction mycologySk. Mizanur Rahman
油
This document provides an introduction to the topic of mycology. It discusses the key characteristics of fungi, including their eukaryotic nature and cell wall composition of chitin and glucan. Fungi can exist in either yeast or mold forms and many medically important fungi are dimorphic, being able to live in both forms. The document outlines different types of fungal infections and methods for diagnosis, including microscopic examination, serology, culture and nucleic acid probes.Clinical Microbiology in Laboratory
Clinical Microbiology in LaboratoryBhoj Raj Singh
油
The document outlines best practices for sample collection in clinical microbiology, focusing on various specimen types including clinical and non-clinical sources, and emphasizes the importance of proper techniques to avoid contamination and diagnostic errors. It details methods for collecting samples from wounds, abscesses, urine, faeces, and various other tissues, while also discussing the significance of antimicrobial susceptibility testing and the methods employed in this process. Furthermore, it touches on the transportation of samples to ensure viable results and the factors affecting microbial recovery.Malaria ppt
Malaria pptNoe Mendez
油
Malaria is caused by Plasmodium parasites transmitted via mosquito bites. The four species that cause malaria in humans are P. vivax, P. ovale, P. malariae, and P. falciparum, with P. falciparum being the deadliest. Symptoms include fever, chills, and headaches. Treatment involves supportive therapies along with antimalarial drugs like chloroquine, primaquine, mefloquine and combinations of pyrimethamine and sulfadoxin. Prevention focuses on controlling mosquito breeding and protecting against mosquito bites.15. principles of infectious disease 1
15. principles of infectious disease 1Ahmad Hamadi
油
This document discusses infection and infectious diseases. It defines infection as the establishment of foreign organisms in a human host, which can result in colonization or infectious disease. It describes the different types of infectious agents (prions, viruses, bacteria, fungi, protozoa, helminths) and discusses their characteristics. It also covers the normal human flora, factors that influence pathogenesis, and the host immune response to infection.Emerging and re-emerging infectious diseases: a key issue of governance for h...
Emerging and re-emerging infectious diseases: a key issue of governance for h...WHO Regional Office for Europe
油
Similar to Emerging And Re Emerging Infectious Disease Vaccines 09 Dec08 Final (20)
Emerging pathogens
Emerging pathogensdeepak deshkar
油
Emerging pathogens are infectious diseases whose incidence is increasing or threatening to increase. They include diseases that have developed antibiotic resistance or spread to new areas. Major emerging pathogens since the 1970s include HIV, Ebola, SARS, and antibiotic-resistant bacteria like MRSA. Factors driving emergence include increased travel and trade, antibiotic overuse, environmental changes, and evolving pathogens. Controlling emerging diseases requires early detection, diagnosis, treatment, and preventing transmission through vectors and contaminated food/water.Emerging infections dr rosni
Emerging infections dr rosnimayazulkifli
油
This document discusses emerging and re-emerging infectious diseases. It defines emerging infections as diseases that are newly appearing or increasing after past existence. Key factors driving emergence include globalization, antibiotic resistance, and environmental changes. The document lists diseases emerging in Malaysia, including avian influenza, dengue, and drug-resistant pathogens. It emphasizes the importance of accurate laboratory diagnosis and strengthened public health measures and surveillance in addressing emerging threats.Zoonotic infection
Zoonotic infectionNorth Coast medical Training College
油
Zoonotic infections are diseases that can spread from animals to humans. Over 60% of infectious diseases in humans are zoonotic. Transmission can occur through direct contact with infected animals, indirect contact, vectors like ticks and mosquitoes, or contaminated food. Common zoonotic diseases include anthrax, bovine tuberculosis, salmonellosis, E. coli, rabies, avian influenza, and prion diseases. Bacteria, viruses, parasites, fungi, and prions can all cause zoonotic diseases. Proper hygiene and food handling can help prevent transmission of zoonotic infections.Microbiology 8th Edition Jacquelyn G Black
Microbiology 8th Edition Jacquelyn G Blacktaherlemay6e
油
Microbiology 8th Edition Jacquelyn G Black
Microbiology 8th Edition Jacquelyn G Black
Microbiology 8th Edition Jacquelyn G BlackMicrobial interactions
Microbial interactionsLani Manahan
油
This document discusses microbial interactions, including both positive and negative interactions. It provides examples of symbiotic relationships between microbes and plants, such as lichens and nitrogen-fixing bacteria in legume roots. Microbial interactions with animals are also discussed, including relationships between rumen microbes and ruminant digestion. The document concludes by examining the interaction between the human microbiome and the host.Emerging & Re-emerging BacteriaI Infection.pptx
Emerging & Re-emerging BacteriaI Infection.pptxdrshrutkirtigupta
油
Microbes have existed on Earth for billions of years and will likely continue to exist for billions more. Emerging and re-emerging infectious diseases are caused by various factors such as increased antibiotic resistance, changes in human behavior and demographics, ecological changes, and globalization. Some examples of bacterial diseases that emerged in recent decades include Legionnaires' disease, Helicobacter pylori infection, and Lyme disease. Melioidosis caused by Burkholderia pseudomallei is an emerging disease in India, especially among those with diabetes or alcoholism.Rodents & disease.pptx
Rodents & disease.pptxPratimaNeupane4
油
Rodents can spread over 35 diseases to humans directly through contact with rodents or indirectly through ticks/mites/fleas that fed on infected rodents. These diseases include plague, tularemia, salmonellosis, Lassa fever, viral hemorrhagic fevers, hantavirus, and Lyme disease. Changes to rodent populations from food surpluses, deforestation, or climate change can increase risk of transmission to humans. Several specific diseases transmitted include murine typhus from flea bites, rat bite fever from rodent bites/secretions, salmonellosis from Salmonella bacteria, and Weil's disease from contaminated water exposure. Rickettsialpox results from rodEmerging reemerging infections
Emerging reemerging infectionsDrMrsVishwashantiVat
油
This document defines emerging and re-emerging infections. Emerging infections are those whose incidence in humans has increased in the past two decades or are expected to increase. Re-emerging infections were previously clinically silent but have reappeared. Major causes of emerging infections include changes in human behavior, environments, travel, and antimicrobial resistance in known pathogens. The document lists many bacterial, viral, fungal and parasitic pathogens that have emerged since 1972. It describes different modes of transmission including waterborne, foodborne, respiratory, zoonotic, vector-borne and nosocomial.Bloodlytmphatic disease
Bloodlytmphatic diseaseBea Galang
油
This document provides information on various microbial diseases that affect the cardiovascular and lymphatic systems. It discusses topics like sepsis, bacterial infections of the heart, rheumatic fever, tularemia, brucellosis, anthrax, biological weapons, gangrene, animal bites and scratches, plague, relapsing fever, Lyme disease, ehrlichiosis, typhus, spotted fevers, herpes virus infections, viral hemorrhagic fevers, Chagas disease, toxoplasmosis, malaria, and other protozoan infections. Detailed information is provided on the causative agents, symptoms, transmission, and microscopic images of pathogens for many of these diseases.Bloodlytmphatic diusease
Bloodlytmphatic diuseaseBea Galang
油
This document summarizes various microbial diseases that can affect the cardiovascular and lymphatic systems. It discusses topics like sepsis, bacterial infections of the heart, rheumatic fever, tularemia, brucellosis, anthrax, biological weapons, gangrene, animal bites and scratches, plague, relapsing fever, Lyme disease, ehrlichiosis, typhus, spotted fevers, viral infections caused by herpes viruses and cytomegalovirus, viral hemorrhagic fevers, Chagas disease, toxoplasmosis, malaria, and other protozoan infections. Diagrams are provided to illustrate concepts like the tick life cycle, stages of malaria infection, and Plasmodium falBloodlytmphatic diusease
Bloodlytmphatic diuseaseBea Galang
油
This document summarizes various microbial diseases that can affect the cardiovascular and lymphatic systems. It discusses topics like sepsis, bacterial infections of the heart, rheumatic fever, tularemia, brucellosis, anthrax, biological weapons, gangrene, animal bites and scratches, plague, relapsing fever, Lyme disease, ehrlichiosis, typhus, spotted fevers, viral infections caused by herpes viruses and cytomegalovirus, viral hemorrhagic fevers, Chagas disease, toxoplasmosis, malaria, and other protozoan infections. Diagrams are provided to illustrate concepts like the tick life cycle, stages of malaria infection, and Plasmodium falHeart and Lymph system infection and its effects.ppt
Heart and Lymph system infection and its effects.pptSyedMasthani
油
The document outlines various microbial diseases affecting the cardiovascular and lymphatic systems, highlighting sepsis, septicemia, and bacterial infections of the heart such as endocarditis. It discusses the causative agents, transmission methods, and potential treatments for these conditions, along with other diseases like anthrax, plague, and malaria. Additionally, it covers relevant vectors, symptoms, and epidemiology, emphasizing the global impact of these diseases.Selected human infectious diseases part 1
Selected human infectious diseases part 1Jason Sulit
油
This document summarizes various factors that can weaken the human body's defenses against infection. It notes that newborns and older adults have reduced immunity. Other factors include heredity, stress, poor nutrition, medical therapies like chemotherapy that lower resistance, and co-morbid medical conditions such as diabetes. Common pathogens are also outlined, including viruses, bacteria, fungi, protozoa and helminths. The body's normal defenses against various types of infections are then described.zoonotic infection.pptx for students education
zoonotic infection.pptx for students educationaryajayakottarathil
油
This document discusses zoonoses, which are diseases that can be transmitted between animals and humans. It provides examples of bacterial, viral, rickettsial, helminthic, and fungal zoonoses. Factors that influence zoonotic transmission include agricultural operations, handling of animal byproducts, increased animal population densities, and changing environmental conditions. Diseases are transmitted through various routes like feces, aerosols, bites, direct contact, insects, and infected objects. Examples of important zoonotic diseases described include rabies, brucellosis, plague, leptospirosis, Lyme disease, arboviral diseases, toxoplasmosis, anthrax, and tetanus8 infectious
8 infectiousReach Na
油
This document summarizes various infectious agents including prions, viruses, bacteria, fungi, parasites, and arthropods. It describes their characteristics, categories, habitats, life cycles, and examples of diseases they cause in humans. Key points covered include the structures and genomes of viruses, gram staining and shapes of bacteria, obligate intracellular nature of chlamydiae, rickettsiae and mycoplasmas, types of fungi and parasites, and examples of diseases caused by different pathogens.Zoonosis
ZoonosisKamran Afzal, PhD.
油
Zoonoses are diseases that can be transmitted between animals and humans. 60% of emerging infectious diseases are zoonotic. Direct or indirect contact with infected animals puts some people at higher risk, such as farmers and veterinarians. Zoonoses can be caused by viruses, bacteria, parasites, and fungi transmitted through various routes like bites, scratches, aerosols, water, and food. Examples include avian influenza, rabies, anthrax, brucellosis, and toxoplasmosis. Proper hygiene and avoiding contact with sick or high-risk animals can help prevent zoonotic disease transmission.GIDEON Introduction
GIDEON Introductiongideoninfo
油
The document discusses GIDEON, a tool that helps doctors make better decisions in infectious diseases. It provides information on over 9,000 infectious diseases, the pathogens that cause them, diagnostic tools and treatments. It also lists many newly discovered diseases and pathogens in the last few decades. The conclusion states that GIDEON can help doctors through its comprehensive infectious disease information and recommends signing up for a free trial on their website.Ad
More from rwmalonemd (8)
Vaccine Production Strategies Who Working Group B
Vaccine Production Strategies Who Working Group Brwmalonemd
油
The document outlines various strategies for influenza vaccine production, emphasizing the need for sustainable and modern manufacturing technologies. It discusses advancements in vaccine production techniques, including flexible manufacturing facilities and the use of disposables to reduce contamination risks. The document also highlights the importance of fill and finish processes, providing examples of innovative vaccine technologies such as baculovirus and recombinant adenoviral-vectored vaccines.Bridging The Valley Of Death A Tale Of Two Cultures
Bridging The Valley Of Death A Tale Of Two Culturesrwmalonemd
油
This document discusses the challenges of transitioning biotechnology discoveries from research to commercial products, known as crossing the "valley of death". It notes that on average only 1 in 4 to 1 in 5 biotechnology products in development achieve approval due to fundamental differences between the cultures of research and product development. Bridging this gap requires addressing regulatory, capital, and project management challenges throughout the product development process. The future of biotechnology will rely on rigorous project planning, outsourcing, earlier consideration of development pathways, and continual engagement between research and development teams.Accelovance Vaccines And Otc
Accelovance Vaccines And Otcrwmalonemd
油
Accelovance is a CRO with divisions providing clinical trial services including patient recruitment and management, high throughput clinical sites, and a virtual call center. It has offices in North America and China. The document outlines Accelovance's mission to increase productivity and reliability in clinical trials through an integrated approach. It provides details on the various services offered by each division to achieve timely and cost-effective trials for clients. Metrics are presented showing Accelovance achieving enrollment targets ahead of schedule on phase II and III clinical trials compared to other participating sites.Clinical Vaccine Development Introduction
Clinical Vaccine Development Introductionrwmalonemd
油
This document provides an overview of clinical vaccine development from a US perspective. It discusses general considerations for vaccine development including safety, efficacy, disease incidence and risk factors. It reviews key FDA guidance documents on topics like Good Clinical Practice standards and the vaccine approval process. It also covers practical clinical development considerations for vaccine trials including safety evaluation, immunogenicity assessment, route of administration, dosing, and the use of boosters. The document is intended as a guide for those developing new vaccines.Naked DNA And DNA Vaccines A Retrospective
Naked DNA And DNA Vaccines A Retrospectiverwmalonemd
油
The document discusses the origins and future directions of DNA vaccines, focusing on the effectiveness and delivery methods of 'naked' DNA. It highlights challenges such as clearance and inefficient delivery, presenting solutions like nuclease inhibitors and electroporation. The findings demonstrate significant enhancements in immune responses through improved delivery techniques in animal models.Blanchard Y Asociados Srl Clinical Research In La
Blanchard Y Asociados Srl Clinical Research In Larwmalonemd
油
The document provides information about Blanchard & Asociados SRL, a clinical research organization based in Argentina. It details the company's mission to provide tailored, quality services to meet client needs, including GCP audits, quality system creation and consulting, and project management services. The document lists the experience and backgrounds of key personnel, including the executive director Anne Blanchard. It also includes information on research sites and sponsors/CROs the company has worked with.Interpandemic Vaccination Controversy, Challenge, Opportunity
Interpandemic Vaccination Controversy, Challenge, Opportunityrwmalonemd
油
This document discusses the concept of developing "interpandemic vaccines" to provide protection against potential future disease threats, such as pandemic influenza strains or engineered bioweapons, as an alternative to the current approach of developing vaccines only for currently circulating pathogens. It argues that this approach could help constrain the evolution of existing pathogens and mitigate risks from engineered threats. However, it notes there are technical, regulatory, and commercial feasibility challenges to the development and licensure of interpandemic vaccines that would need to be addressed. Support from governmental and public health stakeholders would also be required to pursue this strategy.Teaming With The Federal Government
Teaming With The Federal Governmentrwmalonemd
油
The document provides an overview of engaging with the U.S. government (USG) for developing vaccines and therapeutics, including how to capture USG business through proposal development and understanding their acquisition processes. It details various types of USG grants and contracts, including specific grant categories, and contract types such as fixed-price and cost-reimbursement, as well as requirements for solicitation and proposal submission. It emphasizes the importance of aligning business practices with USG expectations, capturing opportunities effectively, and involves strategies for proposal development and establishing partnerships with USG staff.Ad